Neumora Therapeutics is trading at $0.47, up 10.73%; the reason for the advance remains unclear.
- No clear company-specific announcement or catalyst for the October 16 move was identified; available news listings show no fresh company headline today.
- The biotech sector is lower and major market indexes are mixed, so neither directly explains the gain.
- The move follows a 20.45% rise to $0.43 on October 15, based on the provided price context.